Covid 19 Pandemic Articles & Analysis: Older
378 news found
MedSource Labs understands the critical importance of ensuring clinician access to high-quality medical supplies, as it directly impacts patient care and outcomes. In the face of global challenges, such as supply chain disruptions due to a spike in geopolitical conflicts, the time it takes to move products by sea and air has vastly increased. The costs related to the longer transit time has ...
In his communication dated April 19, 2024, Kunelius emphasized MedSource Labs’ role in manufacturing essential medical devices, such as IV catheters and thermometers and made several proposals to enhance supply chain resilience. ...
As Boleca S.L. commemorates its 30th anniversary, it reflects on a journey marked by resilience and adaptation, particularly highlighted by the onset of the COVID-19 pandemic, which dramatically paused global operations. Boleca S.L. has established itself as a leader in the archipelago’s retreading industry, specialising in retreading tyres ...
Their pioneering research has revolutionized the way we combat infectious diseases and has undoubtedly saved countless lives during the COVID-19 pandemic." In effect, mRNA vaccines have reached the spotlight for a while as a new alternative to conventional vaccines. ...
In the face of global health crises such as the COVID-19 pandemic, the development and production of vaccines have become paramount to safeguarding public health and restoring normalcy. ...
Summary The SurgiCam® HD, a specialized point-of-view camera designed for clinicians, plays a pivotal role in the documentation, education, and analysis of surgical, dental, and veterinary procedures. Its high-quality image and video capturing capabilities make it an indispensable tool in these fields. This innovative camera significantly enhances surgical practices, education, and research ...
The new FDA device classification does not specify the level of microbial reduction, rather it applies to the use described regardless of the level of microbial reduction achieved or claimed. During and after the COVID-19 pandemic, a number of companies marketed their UV microbial reduction products as “disinfection” devices and ...
Emalfarb concluded. “The COVID-19 pandemic brought mRNA technology to the forefront, showing its potential to prevent and treat diseases. ...
On Wednesday, June 7th, during the Providence Business News 2023 Best Places To Work awards ceremony, AVTECH Software was awarded third place within the Small Business category. This is the third consecutive year that our team has received the Best Places To Work Award. It is once again a huge honor for us to be acknowledged for creating a positive work environment, where our employees love to ...
In the wake of the COVID-19 pandemic, BOC Sciences, the world's reputed chemical supplier, declares that it will increase production to offer pharmaceutical impurity standards in bulk to satisfy unmet demands. ...
HM King Philippe and HM Queen Mathilde, currently on a state visit to South Africa until March 27, visited the Afrigen Biologics facility in Cape Town to learn more about how two Belgian companies, Univercells and etherna, are supporting the development of the first African- developed mRNA COVID-19 vaccine. The King and The Queen are accompanied by five ...
ByeTheRNA
SeqOne Genomics, provider of nextgeneration genomic analysis solutions for personalized medicine, announces the appointment of Hervé Pouzoullic as Chief Commercial Officer (CCO). He will lead the commercial development of the company to accelerate its growth and strengthen its international presence. Hervé has more than 25 years of experience in sales, business development and ...
These factors include, but are not limited to, the impact of COVID-19 pandemic on our business and customers; our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including ...
The ongoing COVID-19 pandemic necessitates the need for robust and reliable detection methods to tackle the spread of the virus and to alleviate the severe socio-economic consequences of the disease. Alertgy has partnered with Florida Atlantic University’s (FAU) Immunology and Virology Department to execute a collaborative study on the ...
ByAlertgy
The COVID-19 pandemic has forced many businesses to re-evaluate their workplace policies. ...
Viral Vaccine Manufacturing to control pandemics: The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) has created a global public health crisis. Therefore, urgency in the development of vaccines is of vital importance to control the ...
ByNuvonis
"The urgent need for a new generation of rapid, low-cost, consumer surveillance and diagnostics tools has been made extremely clear in the current COVID-19 pandemic," said Roswell President & CEO Paul Mola. "In that area, the Roswell molecular electronic platform will transform the way infectious diseases are detected, with powerful new ...
These factors include, but are not limited to, the impact of COVID-19 pandemic on our business and customers; our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including ...
VeriSIM Life has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $255,908 to conduct research and development (R&D) work on rapid repurposing and translation of approved and investigational drugs for COVID-19 using its patented artificial intelligence (AI) driven biosimulation platform, BIOiSIM. ...
These factors include, but are not limited to, the impact of COVID-19 pandemic on our business and customers; our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including ...